bibliographicCitation |
Kim DY, Lee DH, Jang SJ, Kim SW, Suh C, Lee JS. Phase II Study of S-1 Plus Either Irinotecan or Docetaxel for Non-small Cell Lung Cancer Patients Treated with More Than Three Lines of Treatment. Cancer Res Treat. 2011 Dec;43(4):212–6. PMID: 22247705; PMCID: PMC3253862. |